July 17, 2014, Prof. Ke Chuankui speaker's lecture "Cordyceps research on aspects of" scheduled in the company on the 5th floor multi-purpose hall.

Ke Chuankui served as chief engineer Pharmaceutical Co., Ltd., Hangzhou, East China and the US, Zhejiang Deqing Beik Pharmaceutical Co., Ltd., Director of Hangzhou nine source gene, general manager of Hangzhou Keshi Biotechnology Co., Ltd., Hangzhou Taishi Biotechnology Limited Directors Long, Healthy Product Safety Research Association, vice chairman of Zhejiang Province, a professor of Engineers, bio-industry experts, Chinese caterpillar fungus industrialization successful research first person national medical system model workers, enjoy special benefits. 1980-2012, Professor Ke led his team isolated a real Cordyceps species, and large-scale industrial production of Cordyceps sinensis, completed the medicine in a class of drugs - Bailing Capsule; 1990-1993 presided over the completion of China's first organ transplant drugs - cyclosporine oral solution (Cyspin); 1993-1997 presided over the completion of China's first recombinant human granulocyte colony-stimulating factor (G-CSF, granulocyte Ji Fen) and low molecular liver injection (gepirone morpholino); 2007-2013, with its established cell profiling to identify genuine medicine Chinese medicine methods (ZL201110223048); so far published "Cordyceps saying," Zhong Nanshan, academician together and delivered a speech entitled "to write much more than reading science articles Gordon efforts to achieve scientific and rejuvenating dream - our proposal "